"Komplexní neuropsychiatrická péče - neurologie, psychiatrie, dětská neurologie, dětská a dorostová psychiatrie, psychoterapie, klinická psychologie, lékárna, a další služby."

During the past decade, Institut Neuropsychiatricke pece conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Neuropsychiatricke pece" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Amgen" with 3 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Neuropsychiatricke pece" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institut Neuropsychiatricke pece" are "Depressive Disorder, Major" (6 trials), "Schizophrenia" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Migraine" (2 trials) and "Anhedonia" (1 trials). Many other conditions were trialed in "Institut Neuropsychiatricke pece" in a lesser frequency.

Most popular intervention types in "Institut Neuropsychiatricke pece" are "Drug" (17 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AVP-786" (2 trials), "Aticaprant" (2 trials), "BI 1358894" (2 trials) and "SSRI/SNRI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut Neuropsychiatricke pece" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Institut Neuropsychiatricke pece". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Institut Neuropsychiatricke pece, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Neuropsychiatricke pece, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".